SEC Form 4 · accession 0001250853-15-000017
Kindred Biosciences, Inc. · KIN
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Raymond Townsend
Director
Period of report
Jan 26, 2015
Accepted (ET)
Jan 28, 2015 · 7:36 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001561743
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Common StockF1 | $6.96 | Jan 26, 2015 | A | 44,000 | A | — | Jan 26, 2025 | Common Stock | 44,000 | 44,000 | D |
Explanation of responses
- F1The option will vest as to 25% quarterly following the date of grant.